Option Care Health (NASDAQ:OPCH) Shares Gap Up – Here’s What Happened

Option Care Health, Inc. (NASDAQ:OPCH) gapped up prior to trading on Thursday . The stock had previously closed at $29.31, but opened at $30.43. Option Care Health shares last traded at $30.01, with a volume of 177,273 shares.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Barrington Research increased their target price on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $35.00 in a research report on Thursday. UBS Group initiated coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $31.14.

Option Care Health Trading Up 1.7 %

The stock has a fifty day moving average of $24.10 and a 200 day moving average of $27.78. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.07 billion, a PE ratio of 25.06, a PEG ratio of 2.12 and a beta of 1.31.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Option Care Health

Several large investors have recently added to or reduced their stakes in OPCH. Envestnet Asset Management Inc. lifted its stake in shares of Option Care Health by 2.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock worth $6,407,000 after acquiring an additional 6,283 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after acquiring an additional 218,844 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of Option Care Health in the second quarter valued at about $1,014,000. Bank of Montreal Can lifted its holdings in Option Care Health by 2.9% during the second quarter. Bank of Montreal Can now owns 51,667 shares of the company’s stock worth $1,461,000 after buying an additional 1,477 shares during the period. Finally, Squarepoint Ops LLC purchased a new stake in Option Care Health during the second quarter worth $4,979,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.